Rayence Co. Ltd - Asset Resilience Ratio

Latest as of December 2025: 39.81%

Rayence Co. Ltd (228850) has an Asset Resilience Ratio of 39.81% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check strategic asset allocation of Rayence Co. Ltd to assess the company's strategic physical and investment asset allocation.

Liquid Assets

₩104.00 Billion
≈ $70.48 Million USD Cash + Short-term Investments

Total Assets

₩261.22 Billion
≈ $177.02 Million USD All company assets

Resilience Assessment

Very High
Financial Resilience Level

Asset Resilience Ratio Trend (2016–2025)

This chart shows how Rayence Co. Ltd's Asset Resilience Ratio has changed over time. See 228850 equity financing ratio to measure how much of total assets are equity-financed.

Liquid Assets Composition Over Time

This chart breaks down Rayence Co. Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see 228850 market cap.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents ₩0.00 0%
Short-term Investments ₩104.00 Billion 39.81%
Total Liquid Assets ₩104.00 Billion 39.81%

Asset Resilience Insights

  • Very High Liquidity: Rayence Co. Ltd maintains exceptional liquid asset reserves at 39.81% of total assets.
  • This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
  • The company has significant short-term investments, indicating active treasury management.

Rayence Co. Ltd Industry Peers by Asset Resilience Ratio

Compare Rayence Co. Ltd's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Medacta Group SA
SW:MOVE
Medical Devices 0.86%
Double Medical Technology Inc
SHE:002901
Medical Devices 12.59%
Shenzhen New Industries Biomedical
SHE:300832
Medical Devices 9.95%
Jafron Biomedical Co Ltd
SHE:300529
Medical Devices 39.15%
Sinocare Inc
SHE:300298
Medical Devices 3.53%
Xiangyu Medical Co. Ltd. A
SHG:688626
Medical Devices 1.53%
INKON Life Technology Co Ltd
SHE:300143
Medical Devices 5.73%
HOB Biotech Group Corp Ltd
SHG:688656
Medical Devices 2.62%

Annual Asset Resilience Ratio for Rayence Co. Ltd (2016–2025)

The table below shows the annual Asset Resilience Ratio data for Rayence Co. Ltd.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2025-12-31 39.81% ₩104.00 Billion
≈ $70.48 Million
₩261.22 Billion
≈ $177.02 Million
-15.98pp
2024-12-31 55.79% ₩150.21 Billion
≈ $101.79 Million
₩269.22 Billion
≈ $182.44 Million
+2.22pp
2023-12-31 53.57% ₩148.65 Billion
≈ $100.74 Million
₩277.49 Billion
≈ $188.05 Million
+3.67pp
2022-12-31 49.90% ₩130.73 Billion
≈ $88.59 Million
₩262.00 Billion
≈ $177.55 Million
+0.96pp
2021-12-31 48.94% ₩118.33 Billion
≈ $80.19 Million
₩241.80 Billion
≈ $163.86 Million
+3.79pp
2020-12-31 45.15% ₩101.45 Billion
≈ $68.75 Million
₩224.72 Billion
≈ $152.29 Million
+6.72pp
2019-12-31 38.43% ₩89.18 Billion
≈ $60.43 Million
₩232.07 Billion
≈ $157.27 Million
-4.47pp
2018-12-31 42.89% ₩86.27 Billion
≈ $58.46 Million
₩201.13 Billion
≈ $136.30 Million
-3.03pp
2017-12-31 45.92% ₩90.21 Billion
≈ $61.13 Million
₩196.45 Billion
≈ $133.13 Million
+1.21pp
2016-12-31 44.71% ₩85.12 Billion
≈ $57.68 Million
₩190.36 Billion
≈ $129.00 Million
--
pp = percentage points

About Rayence Co. Ltd

KQ:228850 Korea Medical Devices
Market Cap
$70.38 Million
₩103.86 Billion KRW
Market Cap Rank
#20668 Global
#1137 in Korea
Share Price
₩6600.00
Change (1 day)
-1.64%
52-Week Range
₩4895.00 - ₩6990.00
All Time High
₩20930.72
About

Rayence Co., Ltd., together with its subsidiaries, engages in the development, manufacture, and sale of digital X-ray detector products for dental, medical, veterinary, and industrial sectors in South Korea, the United States, Mexico, China, and internationally. The company offers TFT/CMOS X-ray detectors for general radiography, C-arm/RF, mammography, and radiotherapy; and CMOS/Super IGZO TFT/a-… Read more